ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

November 01, 2006 10:49 ET

ProMetic Life Sciences to Present at Rodman & Renshaw Eighth Annual Healthcare Conference

MONTREAL, CANADA--(CCNMatthews - Nov. 1, 2006) - ProMetic Life Sciences Inc. ("ProMetic")(TSX:PLI) announced that its president and chief executive officer, Pierre Laurin, will present at the upcoming Rodman & Renshaw Eighth Annual Healthcare Conference. The presentation is scheduled for 10:35 AM (Eastern Time) on Monday, November 6, 2006. The event will be held from November 6-8, 2006 at the New York Palace Hotel in New York.

Individuals may listen to a live web cast of the presentation by logging on to ProMetic's web site, a few minutes prior to start time to download any necessary software.

The conference will feature presentations from more than 290 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. Details regarding the conference can be obtained at

About ProMetic Life Sciences

ProMetic Life Sciences Inc. is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ enabling technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of inflammation and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D and manufacturing facilities in the UK and business development activities in the US, Europe, Asia and MENA countries (Middle East and North Africa).

Additional information is available on the Company's website at

Contact Information